Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Type II NADH:quinone oxidoreductase is an essential bacterial respiratory enzyme that transfers electrons from cytosolic NAD(P)H to lipid-soluble quinones within the inner cell membrane. Its unique structure—single subunit with FAD cofactor—and lack of proton translocation distinguish it from other respiratory complexes like Complex I. Its absence from mammalian systems underpins its value as an antimicrobial drug target against several pathogenic microorganisms.
Inhibition of bacterial electron transport chain
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Type II NADH:quinone oxidoreductase (NDH-2).